Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Increases By 38.7%

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 181,200 shares, a growth of 38.7% from the February 28th total of 130,600 shares. Based on an average daily trading volume, of 2,900,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 4.2% of the shares of the stock are sold short.

Silo Pharma Stock Down 5.3 %

Shares of NASDAQ SILO opened at $1.25 on Monday. Silo Pharma has a fifty-two week low of $0.77 and a fifty-two week high of $4.50. The business has a fifty day moving average price of $1.50 and a two-hundred day moving average price of $1.24.

Silo Pharma (NASDAQ:SILO) last announced its quarterly earnings data on Friday, March 28th. The company reported ($0.41) earnings per share (EPS) for the quarter. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%. The firm had revenue of $0.02 million for the quarter.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.